R-138727
R-138727, the thiol-containing active metabolite of Prasugrel, is an irreversible platelet P2Y12 receptor inhibitor. R-138727 inhibits ADP-induced platelet aggregation[1].
Product Specifications
CAS Number
[204204-73-9]
UNSPSC
12352005
Target
Drug Metabolite; P2Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/r-138727.html
Solubility
10 mM in DMSO
Smiles
O=C(/C=C1CN(CCC/1S)C(C(C2CC2)=O)C3=CC=CC=C3F)O
Molecular Formula
C18H20FNO3S
Molecular Weight
349.42
References & Citations
[1]Hasegawa M, et al. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor. Thromb Haemost. 2005 Sep;94 (3) :593-8.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-123669/R-138727-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-123669/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![2,5-Dihydroxybenzoic Acid Butylamine Salt [Matrix for MALDI-TOF/MS]](https://cdn.genprice.uk/products/572/8748353714397/imageurl/trc-d679195-10mg.webp)
TRC-D679195-10MG 10 mg
2,5-Dihydroxybenzoic Acid Butylamine Salt [Matrix for MALDI-TOF/MS]
Ask
View Details NBP3-26084JF585 0.1 mL
Rabbit Polyclonal AcmNPV gp64 Protein Antibody [Janelia Fluor 585]
Ask
View Details